GNH USA

Europe — EMA

Oxalizor (Oxaliplatin)

Oxaliplatin, the active ingredient in Oxalizor, is a platinum compound presented as a unknown/unknown for intravenous use. It treats colorectal cancer and other gastrointestinal malignancies in adult patients.

Request sourcing

1
Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxalizor, is a platinum compound presented as a unknown/unknown for intravenous use. It treats colorectal cancer and other gastrointestinal malignancies in adult patients. GNH USA supplies Oxalizor as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

What is Oxaliplatin used for?

Oxalizor acts on the DNA repair pathway of colorectal and the ... .... etc…. - Colorectal cancer:     ...   ....  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... 

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Oxaliplatin
Route
Intravenous Use
Manufacturer
Vocate Φαρμακευτικη Αε
Origin
EU

Related products